---
title: Domperidone + Ranitidine + Simethicone
description: >-
  Domperidone + Ranitidine + Simethicone is prescribed for the relief of
  gastrointestinal discomfort associated with conditions such as dyspepsia,
  gastroesophageal reflux disease (GERD), peptic ulcers, and other related
  disorders. It helps manage symptoms like nausea, vomiting, heartburn,
  bloating,...
is_banned: false
lastModified: '2025-09-22T17:22:09.119Z'
faqs:
  - q: >-
      What is the recommended dosage for Domperidone + Ranitidine +
      Simethicone?**

      **A:**  Dosage is tailored to individual patient needs.  Common adult
      regimens include Domperidone 10mg, Ranitidine 150mg, and Simethicone
      20-50mg, taken 15-30 minutes before meals, up to three times daily.
      Consult a doctor for specific recommendations.
    a: >-
      A:**  Dosage is tailored to individual patient needs.  Common adult
      regimens include Domperidone 10mg, Ranitidine 150mg, and Simethicone
      20-50mg, taken 15-30 minutes before meals, up to three times daily.
      Consult a doctor for specific recommendations.
  - q: >-
      What are the main contraindications for this combination?**

      **A:**  Contraindications include hypersensitivity to any component, GI
      bleeding/obstruction, prolactinoma, QT prolongation, severe hepatic/renal
      impairment, and concomitant use of strong CYP3A4 inhibitors.
    a: >-
      A:**  Contraindications include hypersensitivity to any component, GI
      bleeding/obstruction, prolactinoma, QT prolongation, severe hepatic/renal
      impairment, and concomitant use of strong CYP3A4 inhibitors.
  - q: >-
      What are the potential drug interactions I should be aware of?**

      **A:** Interactions may occur with CYP3A4 inhibitors (e.g., ketoconazole,
      erythromycin) for Domperidone and antacids for Ranitidine. Consult a drug
      interaction database for a complete list.
    a: >-
      A:** Interactions may occur with CYP3A4 inhibitors (e.g., ketoconazole,
      erythromycin) for Domperidone and antacids for Ranitidine. Consult a drug
      interaction database for a complete list.
  - q: >-
      Can this combination be prescribed during pregnancy or breastfeeding?**

      **A:**  Use with caution during pregnancy and breastfeeding.  Discuss the
      risks and benefits with a physician.  Simethicone is generally considered
      safe.
    a: >-
      A:**  Use with caution during pregnancy and breastfeeding.  Discuss the
      risks and benefits with a physician.  Simethicone is generally considered
      safe.
  - q: >-
      What are the common side effects patients might experience?**

      **A:** Common side effects include dry mouth, headache, dizziness,
      constipation, and diarrhea.
    a: >-
      A:** Common side effects include dry mouth, headache, dizziness,
      constipation, and diarrhea.
  - q: >-
      Are there any specific monitoring parameters for this drug?**

      **A:** Monitor ECG for QT prolongation, liver and renal function, and
      electrolyte levels.
    a: >-
      A:** Monitor ECG for QT prolongation, liver and renal function, and
      electrolyte levels.
  - q: >-
      How do the individual components of this combination work?**

      **A:**  Domperidone enhances GI motility and reduces nausea/vomiting.
      Ranitidine decreases stomach acid production. Simethicone breaks down gas
      bubbles.
    a: >-
      A:**  Domperidone enhances GI motility and reduces nausea/vomiting.
      Ranitidine decreases stomach acid production. Simethicone breaks down gas
      bubbles.
  - q: >-
      What should I do if a patient experiences a severe side effect?**

      **A:** Immediately discontinue the medication and contact a medical
      professional for appropriate intervention and management.
    a: >-
      A:** Immediately discontinue the medication and contact a medical
      professional for appropriate intervention and management.
  - q: >-
      Can this medication be crushed or chewed?**

      **A:**  It's preferable to swallow the tablets whole with water unless
      specifically formulated as chewable. Check the specific product
      formulation.
    a: >-
      A:**  It's preferable to swallow the tablets whole with water unless
      specifically formulated as chewable. Check the specific product
      formulation.
  - q: >-
      What is the duration of treatment with this medicine?**

      **A:**  The treatment duration should be determined by a doctor based on
      the patient's condition and response to therapy. It is usually prescribed
      for a short duration.
    a: >-
      A:**  The treatment duration should be determined by a doctor based on the
      patient's condition and response to therapy. It is usually prescribed for
      a short duration.
---
## **Usage**

Domperidone + Ranitidine + Simethicone is prescribed for the relief of gastrointestinal discomfort associated with conditions such as dyspepsia, gastroesophageal reflux disease (GERD), peptic ulcers, and other related disorders. It helps manage symptoms like nausea, vomiting, heartburn, bloating, and flatulence.

This combination drug falls under several pharmacological classifications due to its components:

* **Domperidone:** Prokinetic agent and antiemetic.
* **Ranitidine:** H2-receptor antagonist.
* **Simethicone:** Anti-foaming agent (sometimes categorized as antiflatulent or anti-gas medication).

The medication works by addressing multiple aspects of gastrointestinal distress. Domperidone increases the movement of food through the digestive system, while Ranitidine decreases stomach acid production. Lastly, Simethicone helps relieve gas by breaking down bubbles in the stomach and intestines.

## **Alternate Names**

There is no single international non-proprietary name (INN) for this combination product. The individual components are recognized by their respective INNs.

This triple therapy is marketed under various brand names such as Combidom, Conrin, Elradom Plus, Ranipep D, and RT-Dom-Forte.

## **How It Works**

**Domperidone:**

* **Pharmacodynamics:** Acts as a peripheral dopamine D2-receptor antagonist, enhancing gastrointestinal motility and coordinating gastroduodenal activity. It accelerates gastric emptying, reduces small bowel transit time, and has antiemetic properties.
* **Pharmacokinetics:**  Well-absorbed orally, extensively metabolized by the liver (primarily via CYP3A4), with some renal excretion.
* **Mode of Action:** Blocks dopamine receptors in the chemoreceptor trigger zone, reducing nausea and vomiting. It enhances the release of acetylcholine, which increases the frequency and strength of esophageal and intestinal contractions.

**Ranitidine:**

* **Pharmacodynamics:**  Competitively inhibits the action of histamine at H2 receptors in gastric parietal cells, reducing gastric acid secretion.
* **Pharmacokinetics:** Partially metabolized by the liver and a significant portion excreted unchanged renally.
* **Mode of Action:** Reduced gastric acid secretion decreases irritation and promotes ulcer healing in GERD and peptic ulcers.

**Simethicone:**

* **Pharmacodynamics:** Decreases the surface tension of gas bubbles in the gastrointestinal tract, allowing them to coalesce, aiding in expulsion.
* **Pharmacokinetics:**  Not systemically absorbed; eliminated unchanged in the feces.
* **Mode of Action:**  Physically disrupts gas bubbles, relieving bloating and discomfort without affecting digestive processes.

**Elimination pathways**: Domperidone is mainly metabolized hepatically via CYP3A4. Ranitidine undergoes hepatic and renal elimination, while Simethicone, being unabsorbed, is excreted fecally.

## **Dosage**

The dosage of Domperidone + Ranitidine + Simethicone varies considerably based on individual patient characteristics, the severity of symptoms, and the formulation used.  A doctor should be consulted for precise dosing instructions tailored to each specific situation.

### **Standard Dosage**

#### **Adults:**

A common regimen is Domperidone 10mg, Ranitidine 150mg, and Simethicone 20-50mg taken orally, 15-30 minutes before meals, up to three times a day.  Dosage adjustments might be necessary depending on individual response and tolerance.

#### **Children:**

Pediatric dosing is generally weight-based and should be determined by a pediatrician.  Safety concerns in children include a heightened risk of extrapyramidal symptoms with Domperidone.

#### **Special Cases:**

* **Elderly Patients:** Start with a lower dose due to potential age-related decline in renal and hepatic function.
* **Patients with Renal Impairment:**  Dose reduction, especially for Ranitidine and Domperidone, is crucial.  Renal function tests should guide adjustments.
* **Patients with Hepatic Dysfunction:** Administer with caution as impaired metabolism can lead to higher drug levels, increasing side effects.
* **Patients with Comorbid Conditions:** Carefully individualize the dose, particularly for patients with cardiovascular disease, diabetes, or other relevant conditions, to prevent adverse interactions or exacerbation of existing issues.

### **Clinical Use Cases**

This particular combination isn't typically used in specific clinical settings like intubation, surgical procedures, mechanical ventilation, ICU care, or acute emergency situations. Individual components, like Ranitidine or Domperidone, might be used separately within pre- or post-operative protocols.


### **Dosage Adjustments**

Always review renal and hepatic function test results for necessary dose adjustments. Account for metabolic disorders or genetic polymorphisms affecting drug metabolism.

## **Side Effects**

### **Common Side Effects:**

Dry mouth, headache, dizziness, constipation, diarrhea, abdominal cramps.

### **Rare but Serious Side Effects:**

* Cardiac arrhythmias (QT prolongation) - primarily associated with Domperidone.
* Extrapyramidal symptoms (especially in children) - associated with Domperidone.
* Hypersensitivity reactions.
* Hepatotoxicity (rare).
* Pancreatitis.
* Blood disorders.
* Neuroleptic malignant syndrome.

### **Long-Term Effects:**

Long-term use of Ranitidine has been linked to vitamin B12 deficiency.  Other chronic effects of the combination haven't been extensively studied.


### **Adverse Drug Reactions (ADR):**

* QT prolongation leading to Torsades de Pointes (Domperidone).
* Neuroleptic malignant syndrome (Domperidone - rare).
* Severe allergic reactions.


## **Contraindications**

* Hypersensitivity to any of the components.
* Gastrointestinal hemorrhage, obstruction, or perforation.
* Prolactin-secreting pituitary tumor (prolactinoma).
* QT prolongation or a history of ventricular arrhythmias.
* Severe hepatic or renal impairment.
* Concomitant use of strong CYP3A4 inhibitors.
* Porphyria.

## **Drug Interactions**

* **Domperidone:** Ketoconazole, itraconazole, erythromycin, other CYP3A4 inhibitors, anticholinergic drugs.
* **Ranitidine:** Antacids (reduce absorption), ketoconazole, itraconazole, other H2 receptor blockers, certain antibiotics.
* **Simethicone:**  Can interfere with the absorption of other drugs.


Interactions may also occur with commonly prescribed medications like antibiotics, anticoagulants, and antihypertensives, as well as OTC drugs and supplements. Alcohol, smoking, and certain foods like grapefruit can also impact the metabolism or effects of the individual components.


## **Pregnancy and Breastfeeding**

* **Domperidone:** Use with caution during pregnancy only if clearly needed.  Limited information on breast milk excretion exists.
* **Ranitidine:** Considered relatively safe during pregnancy, but potential risks must be evaluated. Excreted in breast milk; monitor the infant.
* **Simethicone:**  Generally safe during pregnancy and breastfeeding as it lacks systemic absorption.


## **Drug Profile Summary**

* **Mechanism of Action:** Domperidone: Enhances motility; Ranitidine: Reduces acid secretion; Simethicone: Reduces gas.
* **Side Effects:** Dry mouth, headache, dizziness, constipation/diarrhea, extrapyramidal symptoms (rare), cardiac arrhythmias (rare).
* **Contraindications:** Hypersensitivity, GI bleeding/obstruction, prolactinoma, QT prolongation, severe hepatic/renal impairment.
* **Drug Interactions:** CYP3A4 inhibitors (Domperidone), antacids (Ranitidine), other prokinetic agents or H2 receptor antagonists.
* **Pregnancy & Breastfeeding:** Use with caution for Domperidone and Ranitidine; Simethicone is generally safe.
* **Dosage:** Varies based on patient and condition; see detailed Dosage section.
* **Monitoring Parameters:** ECG (QT interval), liver and renal function, electrolyte levels.


## **Popular Combinations**

While the Domperidone + Ranitidine + Simethicone combination is frequently prescribed, some formulations may incorporate additional ingredients, such as other antacids or proton pump inhibitors, for enhanced symptom relief.  These additions are dependent on the specific clinical needs of the patient.

## **Precautions**

* **General Precautions:** Assess renal/hepatic function, electrolyte levels, and cardiac history (QT interval).  Monitor for extrapyramidal symptoms, especially in children.  Avoid concomitant use of strong CYP3A4 inhibitors. Conduct pre-screening for drug allergies and check for drug interactions with other medications.
* **Specific Populations:** Assess risk versus benefit in pregnant and breastfeeding women.  Age-specific dosing is critical, particularly for children and the elderly.  If using the drug with other medications, adjust the dosage according to the specific recommendations.
* **Lifestyle Considerations:**  Alcohol and smoking can interact with Ranitidine and Domperidone, so caution is advisable.  Drowsiness or dizziness may occur; assess the impact on driving or operating machinery.


## **FAQs (Frequently Asked Questions)**


### **Q1: What is the recommended dosage for Domperidone + Ranitidine + Simethicone?**
**A:**  Dosage is tailored to individual patient needs.  Common adult regimens include Domperidone 10mg, Ranitidine 150mg, and Simethicone 20-50mg, taken 15-30 minutes before meals, up to three times daily. Consult a doctor for specific recommendations.

### **Q2: What are the main contraindications for this combination?**
**A:**  Contraindications include hypersensitivity to any component, GI bleeding/obstruction, prolactinoma, QT prolongation, severe hepatic/renal impairment, and concomitant use of strong CYP3A4 inhibitors.

### **Q3: What are the potential drug interactions I should be aware of?**
**A:** Interactions may occur with CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) for Domperidone and antacids for Ranitidine. Consult a drug interaction database for a complete list.

### **Q4: Can this combination be prescribed during pregnancy or breastfeeding?**
**A:**  Use with caution during pregnancy and breastfeeding.  Discuss the risks and benefits with a physician.  Simethicone is generally considered safe.

### **Q5:  What are the common side effects patients might experience?**
**A:** Common side effects include dry mouth, headache, dizziness, constipation, and diarrhea.

### **Q6: Are there any specific monitoring parameters for this drug?**
**A:** Monitor ECG for QT prolongation, liver and renal function, and electrolyte levels.

### **Q7: How do the individual components of this combination work?**
**A:**  Domperidone enhances GI motility and reduces nausea/vomiting. Ranitidine decreases stomach acid production. Simethicone breaks down gas bubbles.

### **Q8: What should I do if a patient experiences a severe side effect?**
**A:** Immediately discontinue the medication and contact a medical professional for appropriate intervention and management.

### **Q9: Can this medication be crushed or chewed?**
**A:**  It's preferable to swallow the tablets whole with water unless specifically formulated as chewable. Check the specific product formulation.


### **Q10: What is the duration of treatment with this medicine?**
**A:**  The treatment duration should be determined by a doctor based on the patient's condition and response to therapy. It is usually prescribed for a short duration.

